Across TCGA pan-cancer cohorts, MIR4748 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR4748’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR4748 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4748 is over-expressed in tumor.
BRCA, KIRC, and HNSC are the cancer types where MIR4748 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4748 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.